✦ LIBER ✦

A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis

✍ Scribed by S. Diallo; M.A. Aziz; M. Lariviere; J.S. Diallo; I. Diop-Mar; O. N'Dir; S. Badiane; D. Py; H. Schulz-Key; P. Gaxotte; A. Victorius

Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 838 KB
Volume: 80
Category: Article
ISSN: 0035-9203
DOI: 10.1016/0035-9203(86)90262-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A placebo-controlled double-blind trial

A placebo-controlled double-blind trial for the treatment of Bancroftian filariasis with ivermectin or diethylcarbamazine

✍ M. Sabry; H. Gamal; N. El-Masry; M.E. Kilpatrick 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Efficacy and safety of diacerein in oste

Efficacy and safety of diacerein in osteoarthritis of the knee: A double-blind, placebo-controlled trial

✍ Jean-Pierre Pelletier; Michael Yaron; Boulos Haraoui; Patrick Cohen; Menahem A. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety of milnacipran 100 m

Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double-blind, placebo-controlled trial

✍ Lesley M. Arnold; R. Michael Gendreau; Robert H. Palmer; Judy F. Gendreau; Yong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

A multicentre double-blind placebo-contr

A multicentre double-blind placebo-controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety

✍ T. Darcis; M. Ferreri; J. Natens; B. Burtin; P. Deram 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

The efficacy of hydroxyzine was investigated in 110 patients suffering from generalized anxiety, in a double-blind placebo controlled multicentre study. Oral hydroxyzine 50mg/day for four weeks significantly improved standard measurements of anxiety compared with placebo control. These improvements